Publications

354 - IncentivesForRDAntimic_April2011_BIG

Incentives for R&D for New Antimicrobial Drugs

1 April 2011

Antimicrobial resistance (AMR) is becoming a major global public health threat and has begun to command attention from European and US policy makers. An initial focus…

350 - IncorporatingMultipleCriteria_BIG

Incorporating Multiple Criteria in HTA: Methods and Processes

1 March 2011

What a health care system should pay for depends, of course, on the health gain that results.  Health technology assessment (HTA) and cost-effectiveness analysis have become…

Cracks through the ice on a melting glacier in Alaska

Managing Poorly Performing Clinicians: The Value of Independent Help

1 March 2011

The UK’s National Clinical Assessment Agency (NCAS) is designed specifically to provide advice on performance issues, on request, to NHS organisations employing or contracting with doctors,…

349 - PharmaPricing_Differential_Feb11_OP_01_BIG

Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?

1 February 2011

This paper examines the potentially positive impact of differential pricing in Europe and the overall negative effects of international reference pricing (IRP) measures. The authors point…

Cracks through the ice on a melting glacier in Alaska

The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response

1 January 2011

This report examines and makes suggestions for the appropriate use of health technology assessment (HTA) in emerging markets. In particulary, it considers how the stage of development…

348 - priorityreview

Priority Review Vouchers to Encourage Innovation for Neglected Diseases

1 January 2011

Priority Review Vouchers (PRVs) are awarded in the US to companies that gain approval there for a new drug for one of sixteen tropical diseases, under…

341- AComparisonOf_Dec2010_BIG

A Comparison of Alternative Variants of the Lead and Lag Time TTO

12 January 2010

OHE was awarded a UK Department of Health grant to further develop three aspects of health status indexes.  Results of the second of these, advances in…

Biosimilars

Biosimilars: How Much Entry and Price Competition Will Result?

1 December 2010

This publication reports on a seminar intended to encourage further thought about the distinguishing characteristics of the market for biosimilars and the implications of these for…

346 - SciencePolicyResearch_Dec2010_BIG

Science Policy Research: Having an Impact on Policy?

1 December 2010

Professor Ben Martin (Science and Technology Policy Studies at SPRU, University of Sussex) defines science policy research as ’economic, policy, management and organisational studies of science,…